Royal Bank of Canada’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58K Buy
1,832
+1,807
+7,228% +$55.7K ﹤0.01% 5717
2026
Q1
$1K Buy
+25
New +$728 ﹤0.01% 6937
2024
Q2
Sell
-21
Closed -$1K 7452
2024
Q1
$1K Buy
+21
New +$470 ﹤0.01% 6847

Other funds holding REVS

Royal Bank of Canada's REVS Position: Q2 2026 in Review

Royal Bank of Canada increased its Columbia Research Enhanced Value ETF (REVS) stake by 7,228% in Q2 2026, buying an estimated $55.7K and bringing the position to 1,832 shares worth $58K. The position accounts for ﹤0.01% of the portfolio, ranked #5717.

Royal Bank of Canada first reported a position in REVS in Q1 2024 and has held it in 3 quarters since. 37 funds tracked by Wall St. Rank hold REVS as of Q2 2026.

  • Royal Bank of Canada held 1,832 shares of Columbia Research Enhanced Value ETF worth $58K as of Q2 2026.
  • Royal Bank of Canada bought 1,807 Columbia Research Enhanced Value ETF shares in Q2 2026, an estimated $55.7K.
  • Columbia Research Enhanced Value ETF made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #5717 holding.
  • Royal Bank of Canada first reported a position in Columbia Research Enhanced Value ETF in Q1 2024 and has held it in 3 quarters since.
  • 37 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.